Tai Chi Relieves Disease

South West, USA

Short Summary

With home-grown $20 medicinal videos we've sold $700,000 in 1.5 years, selling in 60 countries, and manufacturing in Minneapolis, London and Sydney. The best seller is our Sitting Tai Chi DVD. Our product reviews show we're helping people worldwide.

Overview

Target
US$300,000
Minimum
US$2,500
Investment Raised
US$10,000
Previous Rounds US$80,000
Stage Profitable
Investor Role Any

Highlights

  • $686,000 in sales in the last 18 months
  • Selling in 60 countries, manufacturing in Minneapolis, London & Sydney
  • Inexpensive, easy, at-home medical product for seniors and older adults
  • Legitimate claim that our products can benefit hundreds of medical issues
  • Amazon top best seller in two different categories
Please note: Investing in early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. This platform is targeted solely at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. This information has not been approved as a financial promotion, and you must carry out your own due diligence.

Ask a question

Got a question about this project?

Sign up to view the full pitch

It's free to discover the next big thing

Already have an account?

Similar Projects

Pro
100% raised

Online Counseling Tech

location_on West, USA

Wellin5 is a mental health startup that connects the employee with counsellors for online counselling via PC/Mobile. We are quickly growing as the easy alternative to traditional counselling for employees experiencing anxiety, stress & depress

US$ 1,000,000

Target

US$ 25,000

Min per Investor

Pro
0% raised

Tap into Senior Market

location_on North East,

Rapidly growing outpatient rehab business serving the 65+ market in four states.

US$ 300,000

Target

US$ 20,000

Min per Investor

Pro
6% raised

Clinical Trials Start-Up

location_on West, USA

The requested funds of $300,000 for Kalo Clinical Research will be used for start-up costs and initial operating expenses while projected income is still in accounts receivable and additional trials are still being generated.

US$ 300,000

Target

US$ 20,000

Min per Investor

load one similar proposal